Le Lézard
Classified in: Health, Science and technology
Subject: SVY

InventHelp Inventors Develop Fashionable Monitoring Device for Alzheimer's Patients (LUV-154)


PITTSBURGH, April 20, 2021 /PRNewswire/ -- "We wanted to create an improved location monitoring system to safeguard Alzheimer's patients," said one of two inventors, from Harvey, LA., "so we invented the ALZHEIMER'S ALERT. Our stylish design encourages Alzheimer's patients to wear the monitoring device on a daily basis."

The invention provides an effective way for a caregiver to monitor the location of an Alzheimer's patient. In doing so, it offers an attractive alternative to traditional medical-style bracelets and devices. As a result, it increases precision and it provides added safety and peace of mind. The invention features a fashionable and functional design that is easy to wear and use so it is ideal for Alzheimer's patients, caregivers and care facilities. Additionally, it is producible in design variations and a prototype is available.

The original design was submitted to the Louisville sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-LUV-154, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

SOURCE InventHelp


These press releases may also interest you

at 19:30
Astellas' XTANDItm (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Astellas Pharma Inc....

at 19:15
New Study in Colorado Reveals Alarming Rates of Colorado Teens Missing School
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...

at 19:05
Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for Drug Discovery and Development
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...

at 18:00
Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plustm, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:45
BioSyent to Attend Planet MicroCap Showcase
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th ? May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent,...

at 17:44
Honoring Audrey Beverly Christy Mastroianni at United Breast Cancer Foundation's Mattress and Pink Bag Event: "Gifts of Comfort and Hope" in Warwick, Rhode Island
United Breast Cancer Foundation (UBCF) is proud to host a heartfelt event dedicated to honor the memory of Audrey Beverly Christy Mastroianni, a remarkable Rhode Island woman who bravely battled breast cancer. The "Gifts of Comfort and Hope" Mattress...

More news about Health...


News published on and distributed by: